Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000704068 | SCV000833001 | uncertain significance | Fanconi anemia | 2024-12-25 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 890 of the FANCA protein (p.Ser890Asn). This variant is present in population databases (no rsID available, gnomAD 0.006%). This missense change has been observed in individual(s) with Fanconi anemia and epithelial ovarian cancer (PMID: 32546565, 35854323). ClinVar contains an entry for this variant (Variation ID: 580508). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt FANCA protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Sema4, |
RCV000704068 | SCV002534966 | uncertain significance | Fanconi anemia | 2021-11-15 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV005021095 | SCV005644460 | uncertain significance | Fanconi anemia complementation group A | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000704068 | SCV002092590 | uncertain significance | Fanconi anemia | 2019-10-28 | no assertion criteria provided | clinical testing |